These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3356924

  • 21. Sulfonylurea-induced factitious hypoglycemia in a nondiabetic nurse.
    Walfish PG, Kashyap RP, Greenstein S.
    Can Med Assoc J; 1975 Jan 11; 112(1):71-2. PubMed ID: 803250
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Oral antidiabetic drugs].
    Z Allgemeinmed; 1975 Feb 20; 51(5):235. PubMed ID: 1130116
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sulfonylurea-induced hypoglycaemia: use of octreotide.
    Hanchard B, Boulouffe C, Vanpee D.
    Acta Clin Belg; 2009 Feb 20; 64(1):56-8. PubMed ID: 19317242
    [Abstract] [Full Text] [Related]

  • 32. Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.
    Becker ML, Visser LE, Trienekens PH, Hofman A, van Schaik RH, Stricker BH.
    Clin Pharmacol Ther; 2008 Feb 20; 83(2):288-92. PubMed ID: 17597710
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB.
    Journ Annu Diabetol Hotel Dieu; 1984 Feb 20; ():183-91. PubMed ID: 6443219
    [No Abstract] [Full Text] [Related]

  • 36. [Speech disorders--disorientation--hemiparesis].
    Sander U.
    Fortschr Med; 1982 Jul 08; 100(26):1262-4. PubMed ID: 7118035
    [No Abstract] [Full Text] [Related]

  • 37. [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report].
    Nakaya M, Oka R, Miyamoto S.
    Nihon Ronen Igakkai Zasshi; 2019 Jul 08; 56(3):336-342. PubMed ID: 31366755
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sulfonylurea-induced prolonged hypoglycemic coma: experience with dexamethasone.
    Unnikrishnan AG, Agrawal NK, Kumar R, Reddy DV, Agrawal JK, Singh SK.
    J Assoc Physicians India; 2003 May 08; 51():530-1. PubMed ID: 12974447
    [No Abstract] [Full Text] [Related]

  • 40. [High sensitivity to sulphonylurea treatment in 2 patients with maturity-onset diabetes of the young type 3].
    Bosselaar M, Hattersley AT, Tack CJ.
    Ned Tijdschr Geneeskd; 2002 Apr 13; 146(15):726-9. PubMed ID: 11980375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.